奥翔药业
(603229)
| 流通市值：85.85亿 | | | 总市值：85.85亿 |
| 流通股本：8.30亿 | | | 总股本：8.30亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,129,135,956.12 | 1,146,561,862.52 | 1,104,801,644.13 | 1,096,287,944.72 |
| 交易性金融资产 | 6,300,863.46 | 4,792,302.45 | 4,944,398.57 | 2,242,570.08 |
| 应收票据及应收账款 | 206,314,556.58 | 280,160,345.53 | 326,512,713.44 | 192,215,593.45 |
| 应收账款 | 206,314,556.58 | 280,160,345.53 | 326,512,713.44 | 192,215,593.45 |
| 应收款项融资 | 3,488,625 | 4,464,121 | 4,591,814.9 | 4,363,963.45 |
| 预付款项 | 2,196,824.87 | 9,762,927.35 | 3,340,338.62 | 1,210,873.16 |
| 其他应收款合计 | 2,912,597.38 | 1,487,528.73 | 2,570,103.09 | 1,633,979.15 |
| 存货 | 424,356,114.91 | 402,020,054.53 | 384,355,661.51 | 400,949,911.46 |
| 其他流动资产 | 19,000,645.26 | 12,442,520.59 | 5,287,238.42 | 10,264,712.4 |
| 流动资产合计 | 1,793,706,183.58 | 1,861,691,662.7 | 1,836,403,912.68 | 1,709,169,547.87 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 其他非流动金融资产 | 72,060,765.18 | 72,060,765.18 | 72,060,765.18 | 72,060,765.18 |
| 固定资产 | 526,861,022.49 | 534,847,230 | 547,712,026.85 | 543,215,472.7 |
| 在建工程 | 508,388,175.84 | 505,687,350.84 | 503,220,850.16 | 495,664,029.29 |
| 使用权资产 | 1,047,565.04 | 1,647,026.06 | 1,647,026.06 | 1,946,756.57 |
| 无形资产 | 152,278,882.35 | 153,290,253.57 | 154,476,804.1 | 155,392,216.42 |
| 递延所得税资产 | 1,261,490.25 | 1,364,656.08 | - | 455,987.91 |
| 其他非流动资产 | 4,249,805.48 | 3,972,109.14 | 4,537,327.58 | 3,985,274.45 |
| 非流动资产合计 | 1,266,647,706.63 | 1,273,369,390.87 | 1,284,154,799.93 | 1,273,220,502.52 |
| 资产总计 | 3,060,353,890.21 | 3,135,061,053.57 | 3,120,558,712.61 | 2,982,390,050.39 |
| 流动负债: | | | | |
| 短期借款 | 330,970,949.08 | 310,630,493.61 | 290,088,710.7 | 270,309,905.42 |
| 应付票据及应付账款 | 264,592,277 | 308,824,182.82 | 370,782,794.97 | 351,635,398.76 |
| 其中：应付票据 | 125,168,924.23 | 150,603,488.15 | 156,687,145.07 | 143,554,697.59 |
| 应付账款 | 139,423,352.77 | 158,220,694.67 | 214,095,649.9 | 208,080,701.17 |
| 合同负债 | 1,187,222.14 | 353,801.89 | 10,120,279.04 | 908,529.9 |
| 应付职工薪酬 | 26,888,437.53 | 26,985,595.09 | 22,672,080.11 | 41,370,089.44 |
| 应交税费 | 5,362,420.26 | 6,992,203.43 | 17,716,909.98 | 8,301,562.19 |
| 其他应付款合计 | 1,465,256.08 | 1,817,702.39 | 2,069,216.1 | 937,837.96 |
| 一年内到期的非流动负债 | 1,036,241.73 | 1,256,360.9 | 871,483.26 | 1,036,241.73 |
| 其他流动负债 | 121,912.04 | 33,577.71 | 108,727.63 | 26,150.36 |
| 流动负债合计 | 631,624,715.86 | 656,893,917.84 | 714,430,201.79 | 674,525,715.76 |
| 非流动负债: | | | | |
| 长期借款 | 44,225,000 | 18,790,172.5 | - | - |
| 租赁负债 | 399,978.5 | 857,925.58 | 1,022,684.05 | 1,082,479.96 |
| 递延收益 | 36,803,563.82 | 32,809,586.94 | 33,249,137.32 | 34,890,651.96 |
| 递延所得税负债 | - | - | 83,109.96 | - |
| 非流动负债合计 | 81,428,542.32 | 52,457,685.02 | 34,354,931.33 | 35,973,131.92 |
| 负债合计 | 713,053,258.18 | 709,351,602.86 | 748,785,133.12 | 710,498,847.68 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 830,297,145 | 830,297,145 | 830,297,145 | 830,297,145 |
| 资本公积 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 | 440,225,349.82 |
| 减:库存股 | 50,010,777.47 | 15,537,304.49 | 2,133,186.2 | - |
| 其他综合收益 | -812,529.15 | -823,045.79 | -162,245.1 | -832,491.63 |
| 盈余公积 | 129,879,465.56 | 129,879,465.56 | 129,879,465.56 | 129,879,465.56 |
| 未分配利润 | 997,721,978.27 | 1,041,667,840.61 | 973,667,050.41 | 872,321,733.96 |
| 归属于母公司股东权益合计 | 2,347,300,632.03 | 2,425,709,450.71 | 2,371,773,579.49 | 2,271,891,202.71 |
| 股东权益合计 | 2,347,300,632.03 | 2,425,709,450.71 | 2,371,773,579.49 | 2,271,891,202.71 |
| 负债和股东权益合计 | 3,060,353,890.21 | 3,135,061,053.57 | 3,120,558,712.61 | 2,982,390,050.39 |
| 公告日期 | 2025-10-31 | 2025-08-29 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |